Skip to main content
. 2024 Sep 15;16(9):5130–5136. doi: 10.62347/SOPM3064

Table 1.

Patient and transplant characteristics

Characteristic CMV group (56) Non-CMV group (57) P value
Sex of patient 0.644
    Male 31 (55.36) 34 (59.65)
    Female 25 (44.64) 23 (40.35)
Age of patients 0.024
    Mean ± SD 30±268 23±274
    Min - Max 2-59 1-62
    Median (IQR) 31 27
Underlying disease
    Acute myeloid leukemia 40 (71.43) 42 (73.68) 0.447
    Acute lymphoid leukemia 8 (14.28) 6 (10.52)
    Myelodysplastic syndromes 2 (3.57) 4 (7.02)
    Chronic myeloid leukemia 1 (1.79) 3 (5.26)
    Lymphoma 4 (7.14) 1 (1.75)
    Plasma cellular leukemia 1 (1.79) 0 (0)
    Acute mixed leukemia 0 (0) 1 (1.75)
Disease status 0.459
    CR 35 (62.50) 30 (55.56)
    NR 21 (37.50) 24 (44.44)
HCT-CI 0.932
    Mean ± SD 0.84±0.621 0.82±1.058
    Min - Max 0-3 0-5
    Median (IQR) 1.00 1.00
Donor type 0.689
    HLA mismatched, related 51 (91.07) 54 (94.74)
    HLA mismatched, unrelated 4 (7.14) 2 (3.51)
    Unrelated cord blood 1 (1.79) 1 (1.75)
Graft source < 0.001
    Peripheral blood 39 (69.64) 55 (96.49)
    Bone marrow + Peripheral blood 16 (28.57) 1 (1.75)
    Umbilical cord blood 1 (1.79) 1 (1.75)
Conditioning 0.792
    Reduced intensity 9 (16.07) 8 (14.03)
    Myeloablative 47 (83.93) 49 (85.96)
ABO disparity 0.487
    None 30 (55.56) 30 (52.63)
    Minor 5 (9.26) 11 (19.30)
    Major 14 (25.93) 12 (21.05)
    Bidirectional 5 (9.26) 4 (7.02)
Sex of donor 56 0.825
    Male 39 (73.58) 43 (76.79)
    Female 14 (26.42) 13 (23.21)
Age of donor 0.431
    Mean ± SD 32.92±162.38 34.98±199.94
    Min - Max 9-63 7-59
    Median (IQR) 33.00 38.50
MNC, ×108/kg 0.769
    Mean ± SD 9.80±9.40 10.00±15.67
    Min - Max 4.84-19.32 1.91-23.5
    Median (IQR) 9.54 8.98
CD34+ cell, ×106/kg < 0.001
    Mean ± SD 5.15±5.58 6.88±7.35
    Min - Max 1.05-9.12 1.2-16.92
    Median (IQR) 5.00 6.70